Albemarle Co. (NYSE:ALB) Shares Acquired by HHM Wealth Advisors LLC

HHM Wealth Advisors LLC increased its holdings in shares of Albemarle Co. (NYSE:ALB) by 178.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,252 shares of the specialty chemicals company’s stock after purchasing an additional 802 shares during the period. HHM Wealth Advisors LLC’s holdings in Albemarle were worth $108,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ALB. Quarry LP grew its stake in shares of Albemarle by 1,400.0% during the 3rd quarter. Quarry LP now owns 270 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 252 shares during the period. Trust Co. of Vermont raised its holdings in shares of Albemarle by 606.5% in the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 279 shares during the last quarter. Eastern Bank purchased a new position in Albemarle in the 3rd quarter valued at about $31,000. First Community Trust NA lifted its stake in shares of Albemarle by 55.0% during the fourth quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock valued at $34,000 after buying an additional 142 shares during the period. Finally, MassMutual Private Wealth & Trust FSB grew its stake in Albemarle by 48.9% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 414 shares of the specialty chemicals company’s stock worth $36,000 after acquiring an additional 136 shares during the period. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle Trading Down 4.5 %

Shares of ALB stock opened at $80.40 on Tuesday. The firm has a market capitalization of $9.45 billion, a P/E ratio of -4.80, a price-to-earnings-growth ratio of 3.65 and a beta of 1.58. Albemarle Co. has a 1 year low of $71.97 and a 1 year high of $143.19. The firm’s fifty day simple moving average is $94.15 and its 200 day simple moving average is $93.17. The company has a current ratio of 2.44, a quick ratio of 1.58 and a debt-to-equity ratio of 0.43.

Insider Transactions at Albemarle

In related news, CEO J Kent Masters sold 2,525 shares of Albemarle stock in a transaction dated Thursday, December 5th. The stock was sold at an average price of $101.12, for a total transaction of $255,328.00. Following the sale, the chief executive officer now directly owns 73,747 shares of the company’s stock, valued at $7,457,296.64. This trade represents a 3.31 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.38% of the company’s stock.

Wall Street Analyst Weigh In

ALB has been the subject of a number of recent analyst reports. Clarkson Capital began coverage on Albemarle in a research report on Tuesday, January 14th. They issued a “buy” rating and a $112.00 price objective for the company. Oppenheimer dropped their price objective on shares of Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Mizuho decreased their target price on shares of Albemarle from $110.00 to $105.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. Wells Fargo & Company boosted their price target on Albemarle from $100.00 to $110.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 8th. Finally, KeyCorp dropped their price objective on shares of Albemarle from $132.00 to $127.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $113.95.

Albemarle Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.